Merck Disputes Patent Board Findings In Federal Circuit Appeal

(October 28, 2019, 10:45 AM EDT) -- WASHINGTON, D.C. — In an Oct. 24 appellant brief, Merck, Sharp & Dohme Corp. maintains that the Patent Trial and Appeal Board erred in confirming as patentable various claims of three patents relating to an implantable medical device (Merck, Sharp & Dohme Corp. v. Microspherix LLC, Nos. 19-2197, -2200, -2208, Fed. Cir.)....